152 related articles for article (PubMed ID: 32104311)
21. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
[TBL] [Abstract][Full Text] [Related]
22. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
Hashimoto Y; Shimizu T; Mima Y; Abu Lila AS; Ishida T; Kiwada H
Toxicol Appl Pharmacol; 2014 May; 277(1):30-8. PubMed ID: 24632081
[TBL] [Abstract][Full Text] [Related]
23. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.
Wang C; Cheng X; Su Y; Pei Y; Song Y; Jiao J; Huang Z; Ma Y; Dong Y; Yao Y; Fan J; Ta H; Liu X; Xu H; Deng Y
Int J Nanomedicine; 2015; 10():3533-45. PubMed ID: 25999716
[TBL] [Abstract][Full Text] [Related]
24. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
[TBL] [Abstract][Full Text] [Related]
25. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes.
Xu H; Wang KQ; Deng YH; Chen DW
Biomaterials; 2010 Jun; 31(17):4757-63. PubMed ID: 20303164
[TBL] [Abstract][Full Text] [Related]
26. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.
Ishihara T; Takeda M; Sakamoto H; Kimoto A; Kobayashi C; Takasaki N; Yuki K; Tanaka K; Takenaga M; Igarashi R; Maeda T; Yamakawa N; Okamoto Y; Otsuka M; Ishida T; Kiwada H; Mizushima Y; Mizushima T
Pharm Res; 2009 Oct; 26(10):2270-9. PubMed ID: 19633820
[TBL] [Abstract][Full Text] [Related]
27. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
[TBL] [Abstract][Full Text] [Related]
28. A noticeable phenomenon: thiol terminal PEG enhances the immunogenicity of PEGylated emulsions injected intravenously or subcutaneously into rats.
Wang C; Cheng X; Sui Y; Luo X; Jiang G; Wang Y; Huang Z; She Z; Deng Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):744-51. PubMed ID: 24129310
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions.
Liu M; Su Y; Chen M; Wang J; Liu M; Dai Y; Wang C; Luo X; Lai C; Liu M; Ding J; Li C; Hu Y; Tang X; Liu X; Deng Y; Song Y
J Control Release; 2022 Mar; 343():657-671. PubMed ID: 34954252
[TBL] [Abstract][Full Text] [Related]
30. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.
Li C; Cao J; Wang Y; Zhao X; Deng C; Wei N; Yang J; Cui J
J Pharm Sci; 2012 Oct; 101(10):3864-76. PubMed ID: 22777607
[TBL] [Abstract][Full Text] [Related]
31. The Contribution of PEG Molecular Weights in PEGylated Emulsions to the Various Phases in the Accelerated Blood Clearance (ABC) Phenomenon in Rats.
Jiao J; Jiao X; Wang C; Wei L; Wang G; Deng Y; Song Y
AAPS PharmSciTech; 2020 Nov; 21(8):300. PubMed ID: 33140142
[TBL] [Abstract][Full Text] [Related]
32. The effect of monosialylganglioside mix modifying the PEGylated liposomal epirubicin on the accelerated blood clearance phenomenon.
Zhang T; Zhou S; Kang L; Luo X; Liu Y; Song Y; Liu X; Deng Y
Asian J Pharm Sci; 2017 Mar; 12(2):134-142. PubMed ID: 32104322
[TBL] [Abstract][Full Text] [Related]
33. Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo.
Wang F; Wu Y; Zhang J; Wang H; Xie X; Ye X; Peng D; Chen W
Drug Metab Dispos; 2019 Apr; 47(4):364-376. PubMed ID: 30674617
[TBL] [Abstract][Full Text] [Related]
34. Anti-PEG IgM Production via a PEGylated Nanocarrier System for Nucleic Acid Delivery.
Abu Lila AS; Ishida T
Methods Mol Biol; 2019; 1943():333-346. PubMed ID: 30838627
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of PEGylated liposome-associated proteins relating to the accelerated blood clearance phenomenon by combination with shotgun analysis and conventional methods.
Kawanishi M; Hashimoto Y; Shimizu T; Sagawa I; Ishida T; Kiwada H
Biotechnol Appl Biochem; 2015; 62(4):547-55. PubMed ID: 25196743
[TBL] [Abstract][Full Text] [Related]
36. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance.
Kaminskas LM; McLeod VM; Porter CJ; Boyd BJ
J Pharm Sci; 2011 Nov; 100(11):5069-77. PubMed ID: 21721002
[TBL] [Abstract][Full Text] [Related]
37. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
Ishida T; Kiwada H
Yakugaku Zasshi; 2008 Feb; 128(2):233-43. PubMed ID: 18239370
[TBL] [Abstract][Full Text] [Related]
38. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
[TBL] [Abstract][Full Text] [Related]
39. [Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers].
Koide H; Asai T; Hatanaka K; Shimizu K; Yokoyama M; Ishida T; Kiwada H; Oku N
Yakugaku Zasshi; 2009 Dec; 129(12):1445-51. PubMed ID: 19952519
[TBL] [Abstract][Full Text] [Related]
40. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles.
Koide H; Asai T; Kato H; Ando H; Shiraishi K; Yokoyama M; Oku N
Int J Pharm; 2012 Aug; 432(1-2):75-9. PubMed ID: 22562054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]